ESG Strategies & Goals
- Home
- Sustainability
- ESG Strategies & Goals
ESG Strategies & Goals
Senhwa Biosciences was founded in 2012, with the corporate philosophy of "Bringing Hope to Life". The company is committed to the core sustainable values of "Accelerating new drug development for faster market entry" and "Providing solutions to unmet medical needs to make the world a better place". Senhwa has established seven key development strategies under three major areas: Environment, Social, and Governance (ESG), which include "Environmental Sustainability," "Talent Development," "Innovative R&D," "Social Engagement," "Corporate Governance," "Cybersecurity," and "Product Ethics and Safety."
Goal
Looking to the future, Senhwa Biosciences will continue to focus on clinical development as the foundation, with basic research as a complement. The company is committed to a business model that combines strategic planning with professional execution capabilities, actively promoting new drug development activities in line with ESG principles. At the same time, Senhwa will deepen international collaborations and build a competitive, diversified product portfolio and patent layout, leveraging global new drug development resources and regulatory advantages to fulfill its commitment to sustainable development and social responsibility.